Icatibant

The icatibant outcome survey: 10 years of experience with icatibant for patients with hereditary angioedema

177.

Maurer, M.+, Aberer, W., Caballero, T., Bouillet, L., Grumach, A. S., Botha, J., Andresen, I., and Longhurst, H. J. for the IOS study group: the icatibant outcome survey: 10 years of experience with icatibant for patients with hereditary angioedema. Clin. Exp. Allergy 2022: 52; 1048-1058. IF: 6.10

r.177

The icatibant outcome survey: 10 years of experience with icatibant for patients with hereditary angioedema Read More »

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey

263 Longhurst, H. J.+, Zanichelli, A., Caballero, T., Bouillet, L., Aberer, W., Maurer, M. Fain, O., Fabien, V., and Andresen, I.: Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey. Clin. Exp. Immunol. 2017: 188; 148-153. IF: 3.54

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey Read More »

Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey

214 Longhurst, H.+, Aberer, W., Bouillet, L., Caballero, T., Fabien, V., Zanichelli, A., and Maurer, M.: Analysis of characteristics associated with reinjection of icatibant: results from the icatibant outcome survey. Allergy Asthma Proc. 2015: 36; 399-406. IF: 2.70

Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey Read More »

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

212 Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals Read More »